Edgewise Therapeutics, Inc. (EWTX)
30.61
-0.35
(-1.13%)
USD |
NASDAQ |
May 01, 16:00
30.60
-0.01
(-0.03%)
After-Hours: 20:00
Edgewise Therapeutics EPS Diluted (Quarterly) : -0.4737 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -0.341 |
| Nuvalent, Inc. | -1.585 |
| Boston Scientific Corp. | 0.897 |
| Edwards Lifesciences Corp. | 0.6556 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.22M |
| Total Expenses (Quarterly) | 50.22M |
| Enterprise Value | 2.757B |
| Earnings Yield | -5.33% |
| Normalized Earnings Yield | -5.332 |